Detalhe da pesquisa
1.
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.
Cell
; 184(19): 4969-4980.e15, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34332650
2.
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
Cell
; 183(6): 1496-1507.e16, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33171099
3.
Antibody-mediated SARS-CoV-2 entry in cultured cells.
EMBO Rep
; 24(12): e57724, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277394
4.
Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection.
J Virol
; 96(24): e0127022, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453881
5.
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.
Proc Natl Acad Sci U S A
; 117(18): 9981-9990, 2020 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300019
6.
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes.
Nat Chem Biol
; 16(5): 529-537, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152540
7.
Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C.
J Virol
; 94(10)2020 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132241
8.
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.
Proc Natl Acad Sci U S A
; 113(49): E7908-E7916, 2016 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27872306
9.
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences.
PLoS Pathog
; 12(2): e1005431, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26849216
10.
Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocks.
J Virol
; 89(4): 1965-74, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25473043
11.
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.
J Virol
; 89(5): 2507-19, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540368
12.
Common features of mucosal and peripheral antibody responses elicited by candidate HIV-1 vaccines in rhesus monkeys.
J Virol
; 88(22): 13510-5, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25210178
13.
High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infection.
J Virol
; 86(4): 2153-64, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156525
14.
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption.
Sci Transl Med
; 15(695): eabq4490, 2023 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163616
15.
Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein.
Nat Struct Mol Biol
; 30(7): 980-990, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37430064
16.
Structural and functional impact by SARS-CoV-2 Omicron spike mutations.
Cell Rep
; 39(4): 110729, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452593
17.
Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike.
bioRxiv
; 2022 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35547850
18.
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
JCI Insight
; 7(19)2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214224
19.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
medRxiv
; 2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262094
20.
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
Science
; 373(6555): 642-648, 2021 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168070